Palvella Therapeutics (PVLA) Return on Capital Employed (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 656.00 |
| Dec 31, 2025 | 3,587.00 |
| Sep 30, 2025 | -1,311.00 |
| Jun 30, 2025 | -1,264.00 |
| Mar 31, 2025 | 629.00 |
| Dec 31, 2024 | -5,302.00 |
| Sep 30, 2024 | 3,449.00 |
| Jun 30, 2024 | -3,189.00 |
| Mar 31, 2024 | 5,530.00 |
| Dec 31, 2023 | 4,576.00 |
| Sep 30, 2023 | -883.00 |
| Jun 30, 2023 | 2,810.00 |
| Sep 30, 2022 | -344.00 |
| Jun 30, 2022 | -400.00 |
| Mar 31, 2022 | -338.00 |
| Dec 31, 2021 | 59.00 |
| Sep 30, 2021 | 319.00 |
| Jun 30, 2021 | -780.00 |
| Mar 31, 2021 | -538.00 |
| Dec 31, 2020 | -1,492.00 |
| Sep 30, 2020 | -1,109.00 |
| Jun 30, 2020 | 572.00 |
| Mar 31, 2020 | 849.00 |
| Dec 31, 2019 | 1,919.00 |
| Sep 30, 2019 | 234.00 |
| Jun 30, 2019 | -1,307.00 |
| Mar 31, 2019 | -378.00 |
| Dec 31, 2018 | -2,126.00 |
| Sep 30, 2018 | -219.00 |
| Jun 30, 2018 | 970.00 |
| Mar 31, 2018 | 868.00 |
| Dec 31, 2017 | 1,712.00 |
| Sep 30, 2017 | 1,581.00 |
| Jun 30, 2017 | 1,208.00 |
| Mar 31, 2017 | 214.00 |
| Dec 31, 2016 | -1,954.00 |
| Sep 30, 2016 | -691.00 |
| Jun 30, 2016 | 244.00 |
| Mar 31, 2016 | -700.00 |
| Dec 31, 2015 | 1,371.00 |
| Sep 30, 2015 | 3,790.00 |
| Jun 30, 2015 | -4,135.00 |
| Sep 30, 2014 | -26.39 Mn |